Changing Trends and Use of Electronic Clinical Outcome Assessments in Clinical Trials

Implementing electronic Clinical Outcome Assessments (eCOA) has become core to adapting and responding to the disruptions caused by the COVID-19 pandemic.

eCOA not only helps shorten study start-up times and facilitate the collection of COA data on a global scale, it also maintains the integrity of remote data, enabling patients to remain engaged with a trial.

Read this white paper to learn more about:

• Evolving regulatory trends addressing the patient experience and data safety
• Regulatory reliance on the patient perspective to evaluate treatment effectiveness
• Meeting best practice recommendations
• eCOA technology solutions that can adapt to diverse requirements
• Satisfying regulatory security requirements

Read the white paper to understand the guidance put forth by regulatory agencies that drive your ability to successfully implement eCOA.

White Paper from